07:21 ET - Bidding wars are breaking out in the pharmaceuticals sector as big drugmakers look to beef up their portfolios. Denmark's H. Lundbeck has launched a bid worth up to $2.25 billion for Avadel that could upend the latter's deal to be acquired by Alkermes. Merck has unveiled a $9.2 billion deal to buy Cidara Therapeutics after outspending rivals in a bidding battle that went down to the wire, according to the Financial Times. And Pfizer on Thursday wrapped up its acquisition of weight-loss drug startup Metsera after a bidding tussle with Novo Nordisk that drove the potential final price tag up by more than 35%. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
November 14, 2025 07:22 ET (12:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.